ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Advanced Lung Non-Small Cell Carcinoma
Interventions
DIAGNOSTIC_TEST

ctDNA detection

High-depth sequencing method is used to detecting ctDNA.

Trial Locations (1)

410011

RECRUITING

Oncology Department,Second Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
collaborator

Sun Yat-sen University

OTHER

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

collaborator

Fujian Cancer Hospital

OTHER_GOV

collaborator

Third Affiliated Hospital of Third Military Medical University

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

Qinghai Province Tumor Hospital

UNKNOWN

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

Zhejiang Provincial People's Hospital

OTHER

collaborator

Hunan Province Tumor Hospital

OTHER

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

collaborator

Zhejiang Cancer Hospital

OTHER

collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

Inner Mongolia People's Hospital

OTHER

collaborator

Guizhou Provincial People's Hospital

OTHER

collaborator

The Third Xiangya Hospital of Central South University

OTHER

collaborator

Yueyang Central Hospital

OTHER

collaborator

ZhuZhou Central Hospital

OTHER

collaborator

Zhangjiajie Affiliated Hospital of Hunan Normal University

UNKNOWN

collaborator

Loudi Central Hospital

OTHER

collaborator

Chang Sha First Hospital

UNKNOWN

lead

Fang Wu

OTHER